Efferent Labs, based in Charleston, S.C., with operations in Buffalo, N.Y., is engaged in the development and commercialization of their CytoComm™ implantable biosensor for use in pre-clinical animal ...
PHOENIX and THE WOODLANDS, Texas, March 24, 2026 /PRNewswire/ -- Hopper OS, the configurable intelligent healthcare operating system powering better performance, experiences and outcomes across the ...
The idea behind Efferent Labs – implanting a device containing living cells into the body to act as a biologic sensor – has attracted the attention of the scientific community. Although it is ...
Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology. The device, which is injected into a patient or lab animal, contains living cells to measure cellular ...
MOUNT PLEASANT, SC, UNITED STATES, November 13, 2025 /EINPresswire.com/ -- Efferent Labs, an innovator in real-time biosensor systems that enable continuous ...
CHARLESTON, S.C., Aug. 18, 2020 /PRNewswire/ -- Efferent Labs and W. L. Gore & Associates (Gore) today announced a collaboration to explore implantable biosensing for long-term chronic disease ...